Hepatitis B information for healthcare and public health professionals

This clinical advisory addresses increased hepatitis B transmission associated with injection drug use in Southeastern Massachusetts related to the ongoing epidemic of substance use.

This report summarizes hepatitis B data reported to the Bureau of Infectious Disease and Laboratory Sciences.

This report presents data on the diseases reported to the Bureau of Infectious Disease and Laboratory Sciences by healthcare providers and laboratories per regulation (105 CMR 300.000). This report focuses on a subset of these diseases and includes: chlamydia, gonorrhea, hepatitis B, hepatitis C, HIV/AIDS, and syphilis

This report examines HIV and viral hepatitis co-infection in Massachusetts.

Information regarding case reporting and hepatitis B (HBV) case report forms

Information on vaccination rates and when and why hepatitis B vaccine is recommended

Hepatitis B virus (HBV) infection in a pregnant woman poses a serious risk to her infant at birth. Providers involved with the care of pregnant women and their infants should follow certain guidelines discussed on the Perinatal HBV page.

The CDC provides resources for health care providers and public health professionals on a variety of topics, including general information regarding transmission and prevention, statistics about HBV, diagnosis and management of HBV infection, and other resources for health care professionals.